PSTV
PLUS THERAPEUTICS, INC.
Latest Form 4:Purchase$10KbySims Andrew John Hugh MacIntyre (Chief Financial Officer) · filed Nov 5, 2025
PLUS THERAPEUTICS, INC. (PSTV) has 14 SEC Form 4 filings (20 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 1, 2026.
- Industry:Biotechnology
- CEO:Marc H. Hedrick
- Employees:28
- HQ:Austin, TX, US
- IPO:2001-07-11
Insider Buying
$10K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$29.1M
Price slightly stale
| Source | ||||||
|---|---|---|---|---|---|---|
Sims Andrew John Hugh MacIntyreFirst filing | Chief Financial Officer | Purchase | 20,000 | $10K | Nov 5 | SEC ↗ |
Related companies
PLUS THERAPEUTICS, INC. is in the Healthcare sector.